Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Proact - German market continues to be challenging

01 augusti 2025

<a id="bm-comp-a67c9f3d-82ea-44b7-a369-58ae01260f10" name="bm-comp-a67c9f3d-82ea-44b7-a369-58ae01260f10" class="BMCustomAnchor"></a><table><tr><td bm-component-id="a67c9f3d-82ea-44b7-a369-58ae01260f10" style="vertical-align: top; width:100.000000%;"><ul><li>Cancom Q2 PW and cut FY'25 EBITA guidance by -25%, stock -8%</li><li>Blames reluctant customers, and particularly weak Germany</li><li>Germany is 16% for Proact, we expect no quick recovery</li></ul></td></tr></table><a id="bm-comp-12b35dcb-2d6c-43d5-a96a-6edfa96c59e3" name="bm-comp-12b35dcb-2d6c-43d5-a96a-6edfa96c59e3" class="BMCustomAnchor"></a><table><tr><td bm-component-id="12b35dcb-2d6c-43d5-a96a-6edfa96c59e3" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Another profit warning from Cancom</h3><p>German listed peer Cancom PW'd for Q2 yesterday evening and cut its FY'25 guidance on sales by -4% and EBITA by -25%. It blames "continued reluctancy of customers to buy", especially in its core market Germany. Q2 revenues were flat y-o-y, -3% vs FactSet cons but better than the -7% in Q1, while the new FY sales guidance implies -2% growth vs 2024 (vs previously +2% and FactSet cons at +1%). Stock -8% today.</p><h3 class="bm-h3">Slow recovery likely for Proact Germany</h3><p>Proact has also faced challenges in its German operations (part of segment Central) which represented 16% of sales in 2024, where its average organic growth has been -5% over the last two years. Proact is currently in a restructuring process of its German operations, to adapt to a lower market demand and increased focus on its core offering. This has partly been driven by aggressive price pressure from key competitors Bechtle and Cancom. Given yesterday's negative outlook from Cancom for the rest of the year in Germany, we expect no immediate changes to the competitive landscape, but the market to remain challenging near-term.</p></td></tr></table><a id="bm-comp-7b0b8159-b9f1-40ef-be04-b38903639102" name="bm-comp-7b0b8159-b9f1-40ef-be04-b38903639102" class="BMCustomAnchor"></a><table><tr><td bm-component-id="7b0b8159-b9f1-40ef-be04-b38903639102" style="vertical-align: top; width:100.000000%;"></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-04-10 Xplora Technologies - Si si senior Xplora Tech.. Analys
2026-04-09 Proact - Low top-line visibility, better bottom-line Proact Analys
2026-04-07 Nilörn - FX masks underlying stability Nilörn Analys
2026-04-07 Svedbergs Group - UK outlook has become bleaker Svedbergs G.. Analys
2026-04-01 Careium - Entering a growth-focused period Careium Analys
2026-04-01 Medicover - Weather is set to be a drag Medicover Analys
2026-03-31 Midsona - Skipping down Sesame Street Midsona Analys
2026-03-31 Petrolia Noco - Brage builds momentum into 2026 Petrolia Noco Analys
2026-03-30 Cavotec - Industry leading the way Cavotec Analys
2026-03-30 Impact Coatings - Waiting for renewed momentum Impact Coat.. Analys
2026-03-30 I-tech - Another growth breather in Q1e I-tech Analys
2026-03-24 Donkey Republic - A donkey worth riding Donkey Repu.. Analys
2026-03-20 Coor - CMD added confidence in margin target Coor Analys
2026-03-16 Xplora Technologies - Acquires DACH's leading sen... Xplora Tech.. Analys
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys